Back

Targeting PCSK9: expanding knowledge and targeting new frontiers

31 August 2019 (16:05 - 16:20)
Organised by:
Congress Presentation Part of: PCSK9i, changing practice in cardiology: the emerging story Lipids ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor John Kastelein

Antoni van Leeuwenhoek Hospital (AVL), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Introduction
Professor J. Chapman (Paris, FR)
Slides Video
Presentation thumbnail
Insights and lessons from the ODYSSEY outcomes trial: which patients benefit most?
Professor P. Steg (Paris, FR)
Presentation thumbnail
Extending the evidence: what did the FOURIER trial learns us on managing high risk patients?
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
Discussion
Professor J. Chapman (Paris, FR) Professor J. Kastelein (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
PCSK9i, changing practice in cardiology: the emerging story

The Event

Event poster

ESC Congress 2019

31 August 2019 16:05 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia